Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
4
days
Informing the debate: hypomethylating agents/venetoclax or intensive chemotherapy to treat acute myeloid leukemias
Authors
Michael Daunov; Yogen SaunthararajahShow moreShow less
Affiliations
1. Department of Hematology and Oncology, University Hospitals; 2. School of Medicine, Case Western Reserve University; 3. Taussig Cancer Institute, Cleveland ClinicShow moreShow less
61
days
Philadelphia-negative B-cell acute lymphoblastic leukemia developing after treatment for multiple myeloma: a case report
Authors
Chen Glait Santar; Ben-Zion KatzShow moreShow less
Affiliations
1. The Cellular Immunophenotyping Unit, Hematology Institute, Tel Aviv Sourasky Medical CenterShow moreShow less
2
days
The role of radiotherapy in bridging to CAR T-cell therapy for high-grade B-cell lymphoma
Authors
Michael MacManus; Mark DowlingShow moreShow less
Affiliations
1. Peter MacCallum Cancer Centre; 2. The Sir Peter McCallum Department of Oncology, University of Melbourne; 3. Royal Melbourne HospitalShow moreShow less
143
days
The impact of radiotherapy on the therapeutic response of patients treated with CAR T-cell therapy for high-grade lymphoma: a systematic review
Authors
Maïfa Belghoul; Andrea Kuhnl; Timothy Chevassut; Robin Sanderson; George Mikhaeel; Reuben Benjamin; Piers Patton; John JonesShow moreShow less
Affiliations
1. Department of Clinical Experimental Medicine, Brighton and Sussex Medical School; 2. University Hospitals Sussex NHS Trust; 3. King’s College HospitalShow moreShow less
152
days
Linvoseltamab versus elranatamab for triple-class exposed relapsed or refractory multiple myeloma: an indirect treatment comparison
Authors
Joshua Richter; Hans C. Lee; Sundar Jagannath; Jeffrey A. Zonder; James E. Hoffman; Zheng-Yi Zhou; Viviana Garcia-Horton; Mirko Fillbrunn; Hongjue Wang; Matthew Mattera; Timothy J. Inocencio; Yingxin Xu; James Harnett; Tito Roccia; Glenn S. Kroog; Karen Rodriguez Lorenc; Kate Knorr; Qiufei Ma; Naresh BummaShow moreShow less
Affiliations
1. The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai; 2. Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center; 3. Karmanos Cancer Institute, Wayne State University School of Medicine; 4. University of Miami Health System; 5. Analysis Group, Inc.; 6. Regeneron Pharmaceuticals, Inc.; 7. The Ohio State University Comprehensive Cancer CenterShow moreShow less
89
days
Extending the prognostic value of red cell distribution width to nodal T follicular helper cell lymphoma
Authors
Mitsuaki Oura; Daisuke Ikeda; Atsushi Uehara; Rikako Tabata; Kentaro Narita; Masami Takeuchi; Kosei MatsueShow moreShow less
Affiliations
1. Division of Hematology/Oncology, Kameda Medical CenterShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
